Site-Specific Cleavage of RNA and DNA by Complementary DNA−Bleomycin A5 Conjugates
Identifieur interne : 003237 ( Main/Curation ); précédent : 003236; suivant : 003238Site-Specific Cleavage of RNA and DNA by Complementary DNA−Bleomycin A5 Conjugates
Auteurs : Pavel E. Vorobjev [États-Unis] ; Janet B. Smith [États-Unis] ; Inna A. Pyshnaya [États-Unis] ; Asya S. Levina [États-Unis] ; Valentina F. Zarytova [États-Unis] ; Eric Wickstrom [États-Unis]Source :
- Bioconjugate Chemistry [ 1043-1802 ] ; 2003.
Abstract
Bleomycin displays clinical chemotherapeutic activity, but is so nonspecifically toxic that it is rarely administered. It was therefore of interest to determine whether bleomycin could be directed to cleave RNA or DNA at a specific site by conjugation to a complementary oligonucleotide. A 15 nt MYC complementary oligodeoxynucleotide (HMYC55) bearing a 5‘ bleomycin A5 (Blm) residue was designed to base-pair with nt 7047−7061 of human MYC mRNA. Reactivity of the Blm−HMYC55 conjugate (and mismatch controls) with a MYC mRNA 30-mer, a MYC DNA 30-mer, and a MYC 2‘-O-methyl RNA 30-mer, nt 7041−7070, was analyzed in 100 μM FeNH4SO4, 50 mM β-mercaptoethanol, 200 mM LiCl, 10 mM Tris-HCl, pH 7.5, at 37 °C. Cleavage of the substrate RNA or DNA occurred primarily at the junction of the complementary DNA-target RNA duplex, 18−22 nt from the 5‘ end of the RNA. Reaction products with lower mobility than the target RNA or DNA also formed. Little or no reaction was observed with more than three mismatches in a Blm−oligodeoxynucleotide conjugate. Neither the short RNA or DNA cleavage fragments nor the low mobility products were observed in the absence of Fe(II), or the presence of excess EDTA. The target RNA was also cleaved efficiently by bleomycin within a hybrid duplex with a preformed single-nucleotide bulge in the RNA strand. New Blm−oligodeoxynucleotide conjugates containing long hexaethylene glycol phosphate based linkers between oligodeoxynucleotide and bleomycin were designed to target this bulge region. These conjugates achieved 8−18% cleavage of the target RNA, depending on the length of the linker. Blm−oligodeoxynucleotide conjugates thus demonstrated sequence specificity and site specificity against RNA and DNA targets.
Url:
DOI: 10.1021/bc034148u
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000885
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :000885
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000C42
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003272
Links to Exploration step
ISTEX:0BC292B89C21CB379C3D67F83EDA359CE7B78FCALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Site-Specific Cleavage of RNA and DNA by Complementary DNA−Bleomycin A5 Conjugates</title>
<author><name sortKey="Vorobjev, Pavel E" sort="Vorobjev, Pavel E" uniqKey="Vorobjev P" first="Pavel E." last="Vorobjev">Pavel E. Vorobjev</name>
</author>
<author><name sortKey="Smith, Janet B" sort="Smith, Janet B" uniqKey="Smith J" first="Janet B." last="Smith">Janet B. Smith</name>
</author>
<author><name sortKey="Pyshnaya, Inna A" sort="Pyshnaya, Inna A" uniqKey="Pyshnaya I" first="Inna A." last="Pyshnaya">Inna A. Pyshnaya</name>
</author>
<author><name sortKey="Levina, Asya S" sort="Levina, Asya S" uniqKey="Levina A" first="Asya S." last="Levina">Asya S. Levina</name>
</author>
<author><name sortKey="Zarytova, Valentina F" sort="Zarytova, Valentina F" uniqKey="Zarytova V" first="Valentina F." last="Zarytova">Valentina F. Zarytova</name>
</author>
<author><name sortKey="Wickstrom, Eric" sort="Wickstrom, Eric" uniqKey="Wickstrom E" first="Eric" last="Wickstrom">Eric Wickstrom</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0BC292B89C21CB379C3D67F83EDA359CE7B78FCA</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1021/bc034148u</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-JQR124CH-7/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000885</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000885</idno>
<idno type="wicri:Area/Istex/Curation">000885</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C42</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C42</idno>
<idno type="wicri:doubleKey">1043-1802:2003:Vorobjev P:site:specific:cleavage</idno>
<idno type="wicri:Area/Main/Merge">003272</idno>
<idno type="wicri:Area/Main/Curation">003237</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Site-Specific Cleavage of RNA and DNA by Complementary
DNA−Bleomycin A5 Conjugates</title>
<author><name sortKey="Vorobjev, Pavel E" sort="Vorobjev, Pavel E" uniqKey="Vorobjev P" first="Pavel E." last="Vorobjev">Pavel E. Vorobjev</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Laboratory of Nucleic Acid Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Sciences,Novosibirsk 630090, Russia, and Department of Microbiology and Immunology, and Department of Biochemistryand Molecular Pharmacology, Kimmel Cancer Center, and Cardeza Foundation for Hematologic Research,Thomas Jefferson University, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Smith, Janet B" sort="Smith, Janet B" uniqKey="Smith J" first="Janet B." last="Smith">Janet B. Smith</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Laboratory of Nucleic Acid Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Sciences,Novosibirsk 630090, Russia, and Department of Microbiology and Immunology, and Department of Biochemistryand Molecular Pharmacology, Kimmel Cancer Center, and Cardeza Foundation for Hematologic Research,Thomas Jefferson University, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Pyshnaya, Inna A" sort="Pyshnaya, Inna A" uniqKey="Pyshnaya I" first="Inna A." last="Pyshnaya">Inna A. Pyshnaya</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Laboratory of Nucleic Acid Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Sciences,Novosibirsk 630090, Russia, and Department of Microbiology and Immunology, and Department of Biochemistryand Molecular Pharmacology, Kimmel Cancer Center, and Cardeza Foundation for Hematologic Research,Thomas Jefferson University, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Levina, Asya S" sort="Levina, Asya S" uniqKey="Levina A" first="Asya S." last="Levina">Asya S. Levina</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Laboratory of Nucleic Acid Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Sciences,Novosibirsk 630090, Russia, and Department of Microbiology and Immunology, and Department of Biochemistryand Molecular Pharmacology, Kimmel Cancer Center, and Cardeza Foundation for Hematologic Research,Thomas Jefferson University, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Zarytova, Valentina F" sort="Zarytova, Valentina F" uniqKey="Zarytova V" first="Valentina F." last="Zarytova">Valentina F. Zarytova</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Laboratory of Nucleic Acid Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Sciences,Novosibirsk 630090, Russia, and Department of Microbiology and Immunology, and Department of Biochemistryand Molecular Pharmacology, Kimmel Cancer Center, and Cardeza Foundation for Hematologic Research,Thomas Jefferson University, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Wickstrom, Eric" sort="Wickstrom, Eric" uniqKey="Wickstrom E" first="Eric" last="Wickstrom">Eric Wickstrom</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Laboratory of Nucleic Acid Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Sciences,Novosibirsk 630090, Russia, and Department of Microbiology and Immunology, and Department of Biochemistryand Molecular Pharmacology, Kimmel Cancer Center, and Cardeza Foundation for Hematologic Research,Thomas Jefferson University, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Bioconjugate Chemistry</title>
<title level="j" type="abbrev">Bioconjugate Chem.</title>
<idno type="ISSN">1043-1802</idno>
<idno type="eISSN">1520-4812</idno>
<imprint><publisher>American Chemical Society</publisher>
<date type="e-published">2003</date>
<date type="published">2003</date>
<biblScope unit="vol">14</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1307">1307</biblScope>
<biblScope unit="page" to="1313">1313</biblScope>
</imprint>
<idno type="ISSN">1043-1802</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1043-1802</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Bleomycin displays clinical chemotherapeutic activity, but is so nonspecifically toxic that it is rarely administered. It was therefore of interest to determine whether bleomycin could be directed to cleave RNA or DNA at a specific site by conjugation to a complementary oligonucleotide. A 15 nt MYC complementary oligodeoxynucleotide (HMYC55) bearing a 5‘ bleomycin A5 (Blm) residue was designed to base-pair with nt 7047−7061 of human MYC mRNA. Reactivity of the Blm−HMYC55 conjugate (and mismatch controls) with a MYC mRNA 30-mer, a MYC DNA 30-mer, and a MYC 2‘-O-methyl RNA 30-mer, nt 7041−7070, was analyzed in 100 μM FeNH4SO4, 50 mM β-mercaptoethanol, 200 mM LiCl, 10 mM Tris-HCl, pH 7.5, at 37 °C. Cleavage of the substrate RNA or DNA occurred primarily at the junction of the complementary DNA-target RNA duplex, 18−22 nt from the 5‘ end of the RNA. Reaction products with lower mobility than the target RNA or DNA also formed. Little or no reaction was observed with more than three mismatches in a Blm−oligodeoxynucleotide conjugate. Neither the short RNA or DNA cleavage fragments nor the low mobility products were observed in the absence of Fe(II), or the presence of excess EDTA. The target RNA was also cleaved efficiently by bleomycin within a hybrid duplex with a preformed single-nucleotide bulge in the RNA strand. New Blm−oligodeoxynucleotide conjugates containing long hexaethylene glycol phosphate based linkers between oligodeoxynucleotide and bleomycin were designed to target this bulge region. These conjugates achieved 8−18% cleavage of the target RNA, depending on the length of the linker. Blm−oligodeoxynucleotide conjugates thus demonstrated sequence specificity and site specificity against RNA and DNA targets.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003237 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003237 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:0BC292B89C21CB379C3D67F83EDA359CE7B78FCA |texte= Site-Specific Cleavage of RNA and DNA by Complementary DNA−Bleomycin A5 Conjugates }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |